ARIEL3: A phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC) Meeting Abstract
| Authors: | Ledermann, J.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; Leary, A.; Holloway, R.; O'Malley, D. M.; Cameron, T.; Maloney, L.; Goble, S.; Lin, K. K.; Sun, J.; Giordano, H.; Coleman, R. |
| Abstract Title: | ARIEL3: A phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx440.034 |
| Language: | English |
| ACCESSION: | WOS:000411324005094 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx440.034 |
| Notes: | Meeting Abstract: LBA40_PR -- Appears on page 625 of the abstract book -- Source: Wos |
